Mentari Therapeutics, Inc. lost $3.12 per diluted share in fiscal year 2026. The table below carries 7 fiscal years, from 2020 to 2026, and the quarters Mentari Therapeutics, Inc. has filed alongside them.
FY2026 annual
EPS (Diluted)-$3.12
Ticker history: INM became
MTRI
(Mentari Therapeutics, Inc.) on .
Earlier news and filings retain their original names and dates.
View INM history.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
Mentari Therapeutics, Inc. lost $3.12 per diluted share in fiscal year 2026.
Across the 7 fiscal years this page covers, Mentari Therapeutics, Inc. (MTRI) diluted earnings per share went from -$1.71 in fiscal year 2020 to -$3.12 in fiscal year 2026.
Mentari Therapeutics, Inc. (MTRI) reported -$0.42 in diluted earnings per share in Q1 2027.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Mentari Therapeutics, Inc. (MTRI) reported on that line in every period on record.